COVID-19 Long-Term Brain Health Impact
COVID-19 could trigger a brain health time-bomb in the future. If so, what can we do now?
Menu
Alzheimer's & Parkinson's Blog
Parkinson’s Disease is a movement disorder, which affects each person differently.
Parkinson’s Diagnosis Research
How Life-Changing It Is to Test For Parkinson’s Decades Before Symptoms
ParkinZheimer
What’s Is It? And how does it impact the early diagnosis of Parkinson’s and Alzheimer’s?
How COVID-19 Affects Parkinson’s Patients
Learn about the unique challenges of COVID-19 on PD patients and tips on how best to prepare.
FDA Breakthrough Device Designation – Exciting!
One small step for science, one giant leap for Parkinson’s!
ApoE4 – Genetic Link to Alzheimer’s
Is Alzheimer’s hereditary? How does the gene ApoE4 increase Alzheimer’s risk?
Meet the Enemy of Brain Health
What causes Alzheimer’s, Parkinson’s, and other neurodegenerative diseases? Research shows they are linked to certain proteins gone rogue.
Misfolded Proteins’ Link to Neurodegenerative Diseases
What causes neurodegenerative diseases? This article explains what misfolded proteins or prion proteins are and how they affect Alzheimer’s & Parkinson’s.
Traumatic Brain Injury On A Molecular Level
Research shows traumatic brain injury increases the risk of Alzheimer’s. Learn what happens to the brain on the molecular level.
Amyloid Deposits in Non-Alzheimer’s Brains
Alzheimer’s shows Aβ amyloid deposits in the brains. Learn more as we analyze samples from people with mild cognitive impairment.
Smoking Doubles the Risk of Alzheimer’s
Why quit smoking? Top of the list: cigarette smoke causes changes in the brain and leads to Alzheimer’s.
Amyloid-Beta Deposition in Alzheimer’s Brain
Research suggests that brain abnormalities associated with Alzheimer’s can be induced by propagating Amyloid-b misfolded protein.
Misfolded Proteins in Neurodegenerative Diseases
What role do misfolded proteins play in neurodegenerative diseases? Read to learn more.
Test For Alzheimer’s Using Spinal Fluid
Amazing breakthrough! We’re gearing up to offer a test for Alzheimer’s decades before symptoms appear.
Prion War: Our Fight For Brain Health
This Prion War video shows how the prion proteins destroy the brain silently for decades before the onset of symptoms until it’s too late. Prions are proteins gone rogue.
Frequent Misdiagnosis
One in 4 Parkinson’s cases is misdiagnosed initially. Why is diagnosing Parkinson’s such a daunting challenge?
Consider this simple fact: the early signs of Parkinson’s (tremor, stiffness, balance disorders, constipation) overlap substantially with signs of normal aging and other neurological diseases.
The overwhelming misdiagnosis of Parkinson’s is why biomarker-testing is the next critical milestone to empowers doctors with accurate Parkinson’s diagnosis.
Treatment
Patients with early and intermediate-stage Parkinson’s Disease respond initially to drugs that increase dopamine’s brain concentrations. These include:
- Levodopa, and
- Carbidopa
However, long-term treatment with these drugs leads to undesired severe side effects, and the benefits may decrease over time.
More recently, implantation of electrodes deep within the brain and stimulation with electrical pulses may improve voluntary movement in a subset of patients.
There is currently no treatment that slows or stops the progression of Parkinson’s. However, scientists and researchers such as Team Amprion are working hard to accelerate drug development to prevent Parkinson’s.
